Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

A synthetic 28-amino acid peptide that enhances immune function by modulating T-cell activity, used for viral infections and immunodeficiencies.

Quick Stats
Studies 759
Trials 63
Formula C129H215N33O55
Clear All
Utility 2
pubmed 2002

Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Saruc. Murat M; Yuceyar. Hakan H; Kucukmetin. Nurten N; Demir. Mehmet Akif MA; Kandiloglu. Ali Riza...

A small Turkish study gave 21 chronic hepatitis B patients a combo of thymosin‑alpha‑1 and interferon‑alpha for about a year and saw most of them clear the virus and normalize liver enzymes, with few extra side effects beyond what interferon alone causes.

Utility 2
pubmed 2001

The combined treatment of interferon alpha-2a and thymosin alpha 1 for chronic hepatitis C: the 48 weeks end of treatment results.

Kullavanuaya. P P; Treeprasertsuk. S S; Thong-Ngam. D D; Chaermthai. K K; Gonlachanvit. S S; Suwanag...

A small study gave hepatitis C patients a mix of interferon‑alpha2a and the immune‑boosting peptide thymosin‑alpha‑1 for a year. About half cleared the virus and liver enzymes improved, especially in patients who hadn't been treated before. Side effects were mild, like muscle aches and slight hair loss. The results suggest the combo can work, but it needs medical supervision and isn’t a simple DIY fix.

Utility 2
pubmed 1999

Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment.

Bodey. B B; Bodey. B B; Siegel. S E SE; Kaiser. H E HE

The paper maps out the different cell types in the thymus and shows they naturally make thymosin‑alpha‑1 along with many other hormones, acting as a neuro‑endocrine hub that guides T‑cell development. It’s basic science, not a clinical trial, so it doesn’t give dosing or protocol advice for taking the peptide.

Utility 2
pubmed 1997

Involution of the mammalian thymus, one of the leading regulators of aging.

Bodey. B B; Bodey. B B; Siegel. S E SE; Kaiser. H E HE

The paper explains that the thymus, a key organ for making immune cells, gradually shrinks starting soon after birth and keeps losing tissue at about 3‑5% per year until middle age, then slows down. Important thymic hormones like thymosin‑alpha‑1 start dropping as early as age 10, which may contribute to weaker immune function as we get older. Hormones such as testosterone, estrogen, and steroids speed up this shrinkage, while low doses of thyroid hormone can actually make the thymus grow a bit. The authors note that transplanting thymic tissue or giving thymic hormones can partially reverse the loss, suggesting the organ’s health is linked to overall aging.

Utility 2
pubmed 1994

[Thymosin alpha-1 and hybrid proteins consisting of tumor necrosis factor-alpha and thymosin alpha-1 enhance the efficacy of vaccination against the causative agent of plague].

Shmelev. V A VA; Grigor'ev. B V BV; Mozharova. T I TI; Popov. S G SG

In mice and guinea‑pig experiments, giving thymosin‑alpha‑1 or hybrid proteins that combine it with tumor‑necrosis‑factor boosted the immune response to a plague vaccine and helped recover immune function after radiation exposure.

Utility 2
pubmed 1996

Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

Salvati. F F; Rasi. G G; Portalone. L L; Antilli. A A; Garaci. E E

A small study in advanced lung cancer patients found that adding thymosin‑alpha1 and low‑dose interferon‑alpha after chemotherapy didn’t dramatically boost tumor shrinkage, but it did slow disease progression, kept immune cells from dropping, and cut serious blood‑related side effects compared to chemo alone.

Utility 2
pubmed 1996

A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.

Wada. S S; Kinoshita. Y Y; Kamizuru. M M; Asai. Y Y; Iwata. H H; Ikemoto. S S; Hato. F F; Kishimoto....

In rats that got a bladder‑cancer‑causing chemical, injecting a mix called thymosin fraction 5 (TF5) twice a week lowered tumor size and the number of cancers, and it boosted natural‑killer cell activity. The pure peptide thymosin‑alpha‑1 (Tα1) didn’t show these benefits, and neither TF5 nor Tα1 helped mice in the same experiment.

Utility 2
pubmed 1992

[Synthesis of an artificial gene coding for thymosin alpha1 and its expression in Escherichia coli as a hybrid with human tumor necrosis factor].

Korobko. V G VG; Boldyreva. E F EF; Filippov. S A SA; Berkova. N P NP; Dobrynin. V N VN; Shmelev. V...

Scientists built a fake gene to make the immune‑boosting peptide thymosin‑alpha‑1 in bacteria and attached it to another protein (TNF). They made two versions: one that was secreted and stayed active, and another that clumped inside the cells and was less active. They also showed a way to cut out pure thymosin‑alpha‑1 from the fusion protein.

Utility 2
pubmed 1993

Immunoreactive thymosin alpha 1 in human thymus and thymoma.

Naruse. H H; Hashimoto. T T; Yamakawa. Y Y; Iizuka. M M; Yamada. T T; Masaoka. A A

This study measured how much thymosin‑alpha‑1 is naturally present in human thymus tissue and in thymoma tumors. It found that normal thymus makes less of the peptide as people get older, while thymoma tumors contain much higher amounts, especially certain tumor types and those with lots of immune cells. The findings give a biological backdrop but don’t test taking the peptide as a supplement.

Utility 2
pubmed 1993

Synthesis of prothymosin alpha deduced from nucleotide sequence of the murine cDNA and its effect on the impaired T lymphocytes of uremic patients.

Abiko. T T; Sekino. H H

Scientists made the full mouse version of prothymosin alpha in the lab and found that, when added to blood cells from kidney‑failure patients, it helped restore a type of immune cell activity better than the shorter peptide thymosin‑alpha‑1. However, the synthesis was inefficient and the work was only done in a test‑tube, not in real people.

Utility 2
pubmed 1992

Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults.

Weller. F E FE; Shah. U U; Cummings. G D GD; Chretien. P B PB; Mutchnick. M G MG

The study measured normal blood levels of two peptides, thymosin‑alpha‑1 and thymosin‑beta‑4, in a large group of healthy adults and gave average values and ranges. It found that thymosin‑alpha‑1 levels are about 540 pg/ml and don’t change with race, sex, or age, while thymosin‑beta‑4 averages 12.6 ng/ml, slightly rising with age but otherwise unchanged. These numbers serve as reference points for anyone who might test their own levels.

Utility 2
pubmed 1995

[The action of laser radiation on thymic hormone production].

Iarilin. A A AA; Sharova. N I NI; Kochergina. N I NI; Pershin. S B SB; Konchugova. T V TV; Minenkov....

A study found that shining a specific laser on thymus cells in a dish and on the thymus area of rats raised the level of the immune‑boosting protein alpha‑1‑thymosin, while slightly lowering another hormone called thymulin. The effect showed up a day or two after treatment.

Utility 2
pubmed 1996

IL-1, ICAM-1, LFA-3, and hydrocortisone differentially regulate cytokine secretion by human fetal thymic epithelial cells.

Shu. S S; Naylor. P P; Touraine. J L JL; Hadden. J W JW

This lab study shows that human fetal thymic cells naturally release the immune‑boosting peptide thymosin‑alpha‑1, but its release isn’t increased by common immune signals and is actually reduced when cortisol‑like hydrocortisone is present. In simple terms, stress hormones may lower the body’s own production of this peptide, while other signals boost different immune chemicals.

Utility 2
pubmed 1991

Solid-phase synthesis of biologically active fragment 29-111 of rat prothymosin alpha.

Abiko. T T; Sekino. H H

Scientists made a long piece of a rat protein (the 29‑111 fragment of prothymosin alpha) in the lab and tested it on blood from kidney‑failure patients. It boosted a type of immune cell more than the shorter thymosin‑alpha‑1 peptide, but the work was done only in test tubes with a rat version and gave a tiny amount of product. So while it hints the bigger fragment might be stronger, it doesn’t provide a clear, safe way for people to use it.

Utility 2
pubmed 1989

Thymosin enhances the production of IL-1 alpha by human peripheral blood monocytes.

Hu. S K SK; Badamchian. M M; Mitcho. Y L YL; Goldstein. A L AL

The study shows that a thymic extract called TF5 can make immune cells release more of a signaling molecule called IL‑1 alpha, but this effect isn’t caused by the well‑known peptide thymosin‑alpha‑1. It works in a dose‑dependent way in lab‑grown human cells and also triggers a related response in mice.

Utility 2
pubmed 1987

Thymosin alpha 1 levels in human seminal plasma and follicular fluid: implication in germ cell function.

Naz. R K RK; Naylor. P H PH; Goldstein. A L AL

The study found that the immune peptide thymosin‑alpha‑1 is naturally present in male semen and female follicular fluid, and higher levels are linked to better sperm counts, larger semen volume, and more mature eggs. Men and women with infertility tended to have lower levels. While the research is only observational, it suggests that thymosin‑alpha‑1 could serve as a biomarker for reproductive health, but it doesn’t provide a dosing or treatment protocol yet.

Utility 2
pubmed 1987

Thymosin-alpha 1 increases the capability to produce interleukin-3 but not interleukin-2 in nu/nu mice.

Ohta. Y Y; Tezuka. E E; Tamura. S S; Sugawara. M M; Nihira. S S; Imai. S S; Yagi. Y Y

In mice with weak immune systems, giving thymosin‑alpha‑1 a couple of times a week raised the amount of a signaling protein called IL‑3, which helps blood‑forming cells grow, but it didn’t raise IL‑2, another key immune signal. The effect was seen only in the sick mice, not in normal healthy ones, suggesting the peptide works early in T‑cell development and may aid immune recovery rather than boost a healthy immune system.